erlotinibum 150 mg ut erlotinibi hydrochloridum 163.93 mg, lactosum monohydricum 103.82 mg, cellulosum microcristallinum, carboxymethylamylum natricum A et natrii laurilsulfas corresp. natrium 9 mg, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 400, E 171, pro compresso obducto.
Packungsbestandteile
Coated tablets
Active Agent
Dose
Erlotinib
150 mg
BAG: Active Agent
Dose
Erlotinib
150 mg
Inactive agents
Dose
additional_information
Carboxymethylamylum Natricum A
Cellulosum Microcristallinum
E 171
color.
Hydroxypropylcellulosum
Hypromellosum
Überzug
Lactose Monohydrate
103.82 mg
Macrogol
400
Magnesii Stearas
Natrii Laurilsulfas
Pro Compresso Obducto
Source
Data was imported : 08.01.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
